Swedish biotech startup Re:meat has rebranded as Curve, signaling a shift towards a wider protein manufacturing platform for large-volume industrial use. The company's focus now includes applications in food, health, materials, cosmetics, and other protein-driven sectors. Curve's modular bioreactor systems aim to make biomanufacturing more scalable and cost-effective, positioning the company beyond just the cultivated meat sector.

Through their BIOBRIC platform, Curve aims to reduce capital expenditure by up to seventy percent while accelerating process development for precision fermentation and cultivated meat production. The company recently secured one-million-euro funding and collaborates with fermentation and biotech companies on strain and media optimization. Curve's leadership sees a growing demand for affordable protein ingredients across various industries, emphasizing the need for new equipment architectures and integrated software to support industrial-scale biomanufacturing.